Significant contrasts emerge between American and Trans-Atlantic oncology management approaches . Typically , the United States system is based on a highly market-driven system , which often lead to more rapid availability to cutting-edge interventions, but at a possibly increased expense . In contrast , Continental systems are inclined to a highly